Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-25 @ 8:15 PM
Study NCT ID:
NCT07156435
Status:
RECRUITING
Last Update Posted:
2025-09-05
First Post:
2025-08-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Vyxeos® With Clofarabine for Pediatric AML
Sponsor:
Princess Maxima Center for Pediatric Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-19
First Submit QC Date:
None
Study First Post Date:
2025-09-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-09-05
Last Update Post Date Type:
ESTIMATED